Protective role of the HSP90 inhibitor, STA-9090, in lungs of SARS-CoV-2-infected Syrian golden hamsters
Introduction The emergence of new SARS-CoV-2 variants, capable of escaping the humoral immunity acquired by the available vaccines, together with waning immunity and vaccine hesitancy, challenges the efficacy of the vaccination strategy in fighting COVID-19. Improved therapeutic strategies are urgen...
Main Authors: | Luiz Gustavo Teixeira Alves, Morris Baumgardt, Christine Langner, Mara Fischer, Julia Maria Adler, Judith Bushe, Theresa Catharina Firsching, Guido Mastrobuoni, Jenny Grobe, Katja Hoenzke, Stefan Kempa, Achim Dieter Gruber, Andreas Christian Hocke, Jakob Trimpert, Emanuel Wyler, Markus Landthaler |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Open Respiratory Research |
Online Access: | https://bmjopenrespres.bmj.com/content/11/1/e001762.full |
Similar Items
-
Hsp90 Inhibitor STA9090 induced VPS35 related extracellular vesicle release and metastasis in hepatocellular carcinoma
by: Wenchong Tan, et al.
Published: (2022-12-01) -
A biomathematical model of SARS-CoV-2 in Syrian hamsters
by: Sibylle Schirm, et al.
Published: (2024-12-01) -
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations
by: Osama A. Mohammed, et al.
Published: (2023-07-01) -
Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer
by: Lu Wanjun, et al.
Published: (2024-05-01) -
Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
by: Geraldine Nouailles, et al.
Published: (2021-08-01)